论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Suo N, Wang M, Jin Y, Ding J, Gao X, Sun X, Zhang H, Cui M, Zheng J, Li N, Jin X, Jiang S
Received 4 October 2018
Accepted for publication 4 January 2019
Published 15 February 2019 Volume 2019:14 Pages 1241—1254
DOI https://doi.org/10.2147/IJN.S189688
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Justinn Cochran
Peer reviewer comments 2
Editor who approved publication: Dr Mian Wang
Background: Traditional
intravesical instillation treatment in bladder cancer has limited efficacy,
which results in a high frequency of recurrence.
Purpose: The aim
of this study was to report on an epirubicin (EPI)-loaded magnetic multiwalled
carbon nanotube (mMWCNTs-EPI) system for intravesical instillation in place of
the current formulation.
Methods: The
mMWCNTs-EPI system was formulated with carboxylated MWCNTs, Fe3O4 magnetic
nanoparticles, and EPI. Features and antitumor activity of the system were
investigated.
Results: Under the
effect of external magnets, the mMWCNTs-EPI system showed sustained release and
prolonged retention behavior and better antitumor activity than free EPI. The
mMWCNTs-EPI system had higher efficiency in enhancing cytotoxicity and inhibiting
proliferation in vitro and in vivo than free EPI. Our studies also revealed the
atoxic nature of mMWCNTs.
Conclusion: These
findings suggested that mMWCNTs are effective intravesical instillation agents
with great potential for clinical application.
Keywords: carbon
nanotubes, intravesical instillation, epirubicin, intravesical drug delivery